My Ultimate Sign-in System Made Me Invincible-Chapter 501: Finding Themselves In A Tough Spot

The staff recruitment announcement landed differently in boardrooms than it did everywhere else.

The public reaction had been predictable — excitement about the moon, the chef thread, the kitchen assistant math, the counselor framework observation.

The internet had processed it the way it processed everything Nova Technologies released, with the particular mixture of awe and analysis that had become the default register for anything attached to the company’s name.

But the boardrooms were quieter. And the quiet had a different texture.

***

The pharmaceutical sector moved fast, but not in any direction anyone outside those rooms would see.

The "What We Are Not Looking For" section had been read, reread, and forwarded up chains of command within an hour of the announcement dropping. Legal teams were pulled into emergency calls.

The problem wasn’t the language itself. The problem was what the language implied about Nova Technologies’ screening capability. A standard recruitment disclaimer said we prefer candidates motivated by patient care. Nova Technologies said we will identify the difference. Those were not the same statement.

A senior counsel at one of the largest pharmaceutical companies in the United States sat in a conference room at eleven in the evening reading the announcement on his laptop while three colleagues watched from the other side of the table.

"They’re not bluffing," he said. It wasn’t a question.

Nobody disagreed.

The instinct to place someone inside was immediate and understandable. A medical data analyst with the right background, properly briefed, operating within their defined role but observant — that was a reasonable play in almost any other context. The information value of a month inside a functioning nanite deployment facility was incalculable.

The problem was that Nova Technologies had just publicly announced they knew that play existed and would screen for it. Any attempt that failed wasn’t just a failed intelligence operation. It was a documented, public failure.

A company that had demonstrated real-time awareness of global public discourse would almost certainly make an example of a pharmaceutical insider caught trying exactly what the announcement had warned against.

The risk calculation wasn’t close.

"Draft a conflict of interest policy update," the counsel said finally. "Frame it as standard moonlighting guidance. Make it apply to all external clinical engagements. Don’t mention Nova Technologies by name."

It was the only available move that didn’t make things worse.

***

Hospital networks had a different problem, and it was longer-term.

The recruitment announcement had gone out to everyone. That included every nurse, physician, physical therapist, and occupational therapist currently employed by every major hospital system in every country with internet access. Some of them had already applied before their employers had finished reading the document.

HR departments were working through the night in at least a dozen major institutions, trying to construct a coherent policy position before the morning shift started asking questions.

The core tension was simple. A hospital that tried to prevent staff from applying looked obstructive at a moment when the entire world was watching Nova Technologies with something close to reverence. The reputational cost of being the institution that blocked a nurse from going to the moon to help terminal patients was not manageable.

But a hospital that encouraged applications was potentially losing operational capacity for six to eight weeks across multiple departments simultaneously, with no guarantee of when or whether selected staff would return to their previous roles.

And then there was the harder problem. The one that wasn’t in any HR policy framework because it had never needed to be.

A nurse who spent six weeks at Lunar Base Sanctuary would come back changed in ways that were difficult to quantify but easy to predict. They would have witnessed nanite deployment across a hundred complex cases. They would understand, at a practical observational level, what the technology could do in ways that no existing medical literature could provide. They would have worked alongside international colleagues in an environment that had no equivalent in conventional healthcare.

Their relationship with their institution would shift. Not necessarily toward resignation, but toward a perspective that the institution could not match, replicate, or contain. They would know something their employer didn’t. That dynamic was new, and hospital leadership didn’t have a framework for managing it.

One hospital administrator, preparing talking points for a morning all-staff briefing, deleted three drafts before settling on a single line: We support staff who wish to apply and ask that they notify their department head so we can plan coverage accordingly.

It was the only position that didn’t create a larger problem than the one it was trying to manage.

***

The data analyst positions were quiet concerns, but the concerns ran deep in the right rooms.

Three medical data analysts. One month inside a facility running the most significant clinical deployment of any technology in recent history. Their defined role was interpretation and communication of nanite output data to volunteers and observers.

They would not have access to proprietary architecture. Nova Technologies had been explicit about that. But access to architecture and exposure to output data were different things. Someone who spent a month reading, interpreting, and communicating nanite deployment outputs would understand the shape of the system in ways that no external documentation could provide.

Not the how. But the what. What gets measured. What the outputs look like when a spinal cord regenerates. What the data signature of cancer cell elimination looks like in real time. What anomalies appear in the monitoring feed and how the system responds to them.

That wasn’t proprietary technology. It was observational knowledge. And observational knowledge was not covered by any confidentiality agreement in any jurisdiction.

Several technology companies with active research programs in biological computing, nanoscale engineering, and medical AI had reached the same conclusion independently and said nothing about it publicly. They didn’t need to. The analysts they employed were already reading the announcement. 𝒻𝑟𝘦𝘦𝘸ℯ𝒷𝑛𝘰𝓋ℯ𝘭.𝘤𝘰𝘮

***

The old money reaction was the coldest and the most focused.

Thirty-six people were going in. Thirty-six people were coming out.

The announcement had told the world that Lunar Base Sanctuary maintained Earth-equivalent conditions. That orientation would take approximately one week. That the facility was fully operational. That kitchen staff would plan meals across three daily services for volunteers, observers, and staff simultaneously.

Every one of those details about the facility was a data point.

The speculation threads had been running for days about what Lunar Base Sanctuary actually was — its scale, its infrastructure, its construction history, its power systems. Every conclusion the threads had reached was inference built on public statements and livestream footage.

Thirty-six people were about to spend a month there and come home with direct observation.

They would be bound by confidentiality agreements. Nova Technologies had been clear about that. But confidentiality agreements covered proprietary technology and operational infrastructure. They did not cover the general experience of being in a place. The size of the common areas. The quality of the food. Whether the accommodation felt like a research station or something else entirely. Whether the facility felt finished or still in development. Whether the staff who were already there seemed like a skeleton crew or something closer to a permanent population.

None of that was covered by any agreement. All of it was information.

In offices where the long-term picture mattered more than the immediate news cycle, analysts were already preparing briefing frameworks for debriefing contacts who might be selected. Nothing that would trigger the screening Nova Technologies had warned about. Just questions a person might reasonably be asked by anyone who was curious.

How was the food?

What did it look like up there?

Did it feel like they’d been there a long time?

Simple and patient questions. The kind that didn’t look like intelligence gathering until you assembled the answers.

***

What united every boardroom reaction, across every sector, was the same fundamental recognition that had been accumulating since the first Nova Night announcement.

Nova Technologies was not playing the same game.

Every move they made demonstrated awareness of how institutions would respond and had already accounted for it. The "What We Are Not Looking For" section wasn’t a mistake or an oversight. It was deliberate. It was a message to every organization that had already decided to try something, delivered publicly, at a moment when denying receipt was impossible.

They were watching. They had been watching. And they were comfortable letting that be known.

In most industries, that kind of demonstrated awareness was a negotiating position. A signal that you knew what the other party was doing, deployed to create leverage.

Nova Technologies wasn’t deploying it for leverage. They were deploying it because transparency was cheaper than the alternative, and because they had calculated, correctly, that the people who would try anyway were going to try regardless and might as well know the odds.

That was a different kind of confidence than anything the boardrooms were used to dealing with.